We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

$1.4B Zyprexa Deal Could Spark More Qui Tam Suits

Law360 (January 15, 2009, 12:00 AM EST) -- Eli Lilly & Co.'s record-breaking $1.4 billion deal to settle charges that it illegally marketed its anti-psychotic treatment Zyprexa for off-label use could stimulate, one observer says, a wave of false...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.